Por favor, use este identificador para citar o enlazar a este item:
http://hdl.handle.net/10261/262088
COMPARTIR / EXPORTAR:
SHARE CORE BASE | |
Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL | DATACITE | |
Título: | Proceedings from the Inaugural American Initiative in Mast Cell Diseases (AIM) Investigator Conference |
Autor: | Gotlib, Jason; George, Tracy I.; Carter, Melody C.; Austen, K. Frank; Bochner, Bruce; Dwyer, Daniel; Lyons, Jonathan J.; Hamilton, Matthew J.; Butterfield, Joseph H.; Bonadonna, Patrizia; Weiler, Catherine; Galli, Stephen J.; Schwartz, Lawrence B.; Oude Elberink, Hanneke; Maitland, Anne; Theoharides, Theoharis; Ustun, Celalettin; Horny, Hans-Peter; Orfao, Alberto CSIC ORCID ; Deininger, Michael; Radia, Deepti; Jawhar, Mohamad; Kluin-Nelemans, Hanneke C.; Metcalfe, Dean D.; Arock, Michel; Sperr, Wolfgang R.; Valent, Peter; Castells, Mariana; Akin, Cem | Palabras clave: | Systemic mastocytosis Siglec-8 Mast cell activation syndrome Hereditary alpha-tryptasemia Anaphylaxis European Competence Network on Mastocytosis (ECNM) American Initiative in Mast Cell Diseases (AIM) |
Fecha de publicación: | jun-2021 | Editor: | Elsevier | Citación: | Journal of Allergy and Clinical Immunology 147(6): 2043-2052 (2021) | Resumen: | The American Initiative in Mast Cell Diseases (AIM) held its inaugural investigator conference at Stanford University School of Medicine in May 2019. The overarching goal of this meeting was to establish a Pan-American organization of physicians and scientists with multidisciplinary expertise in mast cell disease. To serve this unmet need, AIM envisions a network where basic, translational, and clinical researchers could establish collaborations with both academia and biopharma to support the development of new diagnostic methods, enhanced understanding of the biology of mast cells in human health and disease, and the testing of novel therapies. In these AIM proceedings, we highlight selected topics relevant to mast cell biology and provide updates regarding the recently described hereditary alpha-tryptasemia. In addition, we discuss the evaluation and treatment of mast cell activation (syndromes), allergy and anaphylaxis in mast cell disorders, and the clinical and biologic heterogeneity of the more indolent forms of mastocytosis. Because mast cell disorders are relatively rare, AIM hopes to achieve a coordination of scientific efforts not only in the Americas but also in Europe by collaborating with the well-established European Competence Network on Mastocytosis. | Versión del editor: | http://dx.doi.org/10.1016/j.jaci.2021.03.008 | URI: | http://hdl.handle.net/10261/262088 | DOI: | 10.1016/j.jaci.2021.03.008 | ISSN: | 0091-6749 |
Aparece en las colecciones: | (IBMCC) Artículos |
Ficheros en este ítem:
Fichero | Descripción | Tamaño | Formato | |
---|---|---|---|---|
accesoRestringido.pdf | 15,38 kB | Adobe PDF | Visualizar/Abrir |
CORE Recommender
SCOPUSTM
Citations
9
checked on 03-may-2024
WEB OF SCIENCETM
Citations
10
checked on 20-feb-2024
Page view(s)
38
checked on 03-may-2024
Download(s)
11
checked on 03-may-2024
Google ScholarTM
Check
Altmetric
Altmetric
NOTA: Los ítems de Digital.CSIC están protegidos por copyright, con todos los derechos reservados, a menos que se indique lo contrario.